Literature DB >> 28522653

A Woman with ESRD with Increasing Need for Erythropoietin to Maintain Hemoglobin.

Holly M Koncicki1, Steven Fishbane2.   

Abstract

Entities:  

Keywords:  anemia; erythropoietin; hyperparathyroidism

Mesh：

Substances：

Year:  2017        PMID： 28522653      PMCID： PMC5498344          DOI： 10.2215/CJN.01160117

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  9 in total

Review 1.  Anti-erythropoietin antibodies and pure red cell aplasia.

Authors:  Jerome Rossert; Nicole Casadevall; Kai-Uwe Eckardt
Journal:  J Am Soc Nephrol       Date:  2004-02       Impact factor: 10.121

2.  Occult infection of old nonfunctioning arteriovenous grafts: a novel cause of erythropoietin resistance and chronic inflammation in hemodialysis patients.

Authors:  George M Nassar; Steven Fishbane; Juan Carlos Ayus
Journal:  Kidney Int Suppl       Date:  2002-05       Impact factor: 10.545

Review 3.  Pattern of resistance to erythropoietin-stimulating agents in chronic kidney disease.

Authors:  Oluwatoyin F Bamgbola
Journal:  Kidney Int       Date:  2011-06-22       Impact factor: 10.612

4.  Association of malnutrition-inflammation complex and responsiveness to erythropoiesis-stimulating agents in long-term hemodialysis patients.

Authors:  Manoch Rattanasompattikul; Miklos Z Molnar; Joshua J Zaritsky; Parta Hatamizadeh; Jennie Jing; Keith C Norris; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Nephrol Dial Transplant       Date:  2012-10-08       Impact factor: 5.992

Review 5.  Epoetin-associated pure red cell aplasia: past, present, and future considerations.

Authors:  June M McKoy; Robin E Stonecash; Denis Cournoyer; Jerome Rossert; Allen R Nissenson; Dennis W Raisch; Nicole Casadevall; Charles L Bennett
Journal:  Transfusion       Date:  2008-05-14       Impact factor: 3.157

6.  Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia.

Authors:  D S Rao; M S Shih; R Mohini
Journal:  N Engl J Med       Date:  1993-01-21       Impact factor: 91.245

7.  Anemia and secondary hyperparathyroidism.

Authors:  J Zingraff; T Drüeke; P Marie; N K Man; P Jungers; P Bordier
Journal:  Arch Intern Med       Date:  1978-11

8.  Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients.

Authors:  Kamyar Kalantar-Zadeh; Grace H Lee; Jessica E Miller; Elani Streja; Jennie Jing; John A Robertson; Csaba P Kovesdy
Journal:  Am J Kidney Dis       Date:  2009-04-01       Impact factor: 8.860

9.  Anemia in primary hyperparathyroidism.

Authors:  M Boxer; L Ellman; R Geller; C A Wang
Journal:  Arch Intern Med       Date:  1977-05
  9 in total
  1 in total

1.  Prolyl hydroxylase inhibitor desidustat improves anemia in erythropoietin hyporesponsive state.

Authors:  Amit A Joharapurkar; Vishal J Patel; Samadhan G Kshirsagar; Maulik S Patel; Hardikkumar H Savsani; Chetan Kajavadara; Darshan Valani; Mukul R Jain
Journal:  Curr Res Pharmacol Drug Discov       Date:  2022-04-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.